Prime Medicine (PRME) Depreciation & Amortization (CF) (2021 - 2026)

Prime Medicine (PRME) posted Depreciation & Amortization (CF) of $1.9 million for Q1 2026, down 1.07% on a QoQ basis from $1.9 million in Q4 2025, and up 9.18% year-over-year from $1.7 million in Q1 2025.

Prime Medicine (PRME) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Prime Medicine's Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $1.9 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 9.18% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 14.8% YoY) and the FY2025 annual result came in at $7.3 million, up 19.47% from the prior year.
  • Depreciation & Amortization (CF) was $1.9 million for Q1 2026 at Prime Medicine, down from $1.9 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.9 million in Q3 2025 and bottomed at $293000.0 in Q1 2022.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 279.91% — and 2026, when it advanced 9.18%.
  • Prime Medicine's Depreciation & Amortization (CF) stood at $870000.0 in 2022, then jumped by 43.33% to $1.2 million in 2023, then soared by 37.69% to $1.7 million in 2024, then advanced by 9.26% to $1.9 million in 2025, then retreated by 1.07% to $1.9 million in 2026.
  • Business Quant data shows PRME's Depreciation & Amortization (CF) at $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Prime Medicine 525.98 Mn 525.98 Mn - 1.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.86 Mn
Mar 31, 2026 1.86 Mn
Dec 31, 2025 1.88 Mn
Dec 31, 2025 1.88 Mn
Sep 30, 2025 1.88 Mn
Sep 30, 2025 1.88 Mn
Jun 30, 2025 1.86 Mn
Jun 30, 2025 1.86 Mn
Mar 31, 2025 1.70 Mn
Mar 31, 2025 1.70 Mn
Dec 31, 2024 1.72 Mn
Dec 31, 2024 1.72 Mn
Sep 30, 2024 1.56 Mn
Sep 30, 2024 1.56 Mn
Jun 30, 2024 1.54 Mn
Jun 30, 2024 1.54 Mn
Mar 31, 2024 1.32 Mn
Mar 31, 2024 1.32 Mn
Dec 31, 2023 1.25 Mn
Dec 31, 2023 1.25 Mn